Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| IQV - IQVIA | 4.29% | Add +3.1% | 3,213,582 | $216.99 | $697M | +96,000 | −$24M |
| TMO - Thermo Fisher Scientific | 4.15% | Add +1.5% | 1,242,459 | $543.28 | $675M | +18,600 | −$48M |
| TRU - Transunion | 3.67% | Add +20.6% | 7,462,996 | $79.99 | $597M | +1,274,500 | −$43M |
| BSX - Boston Scientific | 3.45% | Reduce −4.4% | 15,047,257 | $37.27 | $561M | −693,000 | −$136M |
| ARMK - Aramark | 3.02% | Reduce −2.9% | 16,008,017 | $30.63 | $490M | −471,781 | −$129M |
| HWM - Howmet Aerospace | 2.68% | Add +1.5% | 13,837,353 | $31.45 | $435M | +211,000 | −$55M |
| ELV - Elevance Health | 2.45% | Add +7.5% | 826,482 | $482.58 | $399M | +57,707 | +$21M |
| CNC - Centene Del | 2.26% | Add +7.1% | 4,341,194 | $84.61 | $367M | +288,850 | +$26M |
| MA - Mastercard · CL A | 2.23% | Add +6.9% | 1,151,271 | $315.48 | $363M | +74,682 | −$22M |
| YMM - Full Truck Alliance | 2.21% | Add +71.2% | 39,675,743 | $9.06 | $359M | +16,497,000 | +$205M |
| CLVT - Clarivate | 2.09% | Add +181.8% | 24,557,800 | $13.86 | $340M | +15,844,372 | +$194M |
| WAB - Wabtec | 2.02% | Reduce −18.7% | 3,989,933 | $82.08 | $327M | −917,997 | −$145M |
| MSFT - Microsoft | 2.01% | Reduce −1.0% | 1,272,878 | $256.83 | $327M | −13,200 | −$70M |
| GOOG - Alphabet · CL C | 1.93% | Reduce −14.5% | 143,407 | $2,187 | $314M | −24,400 | −$155M |
| DT - Dynatrace | 1.90% | New | 7,847,000 | $39.44 | $309M | +7,847,000 | +$309M |
| AZNN — | 1.88% | Add +29.5% | 4,629,962 | $66.07 | $306M | +1,053,778 | +$69M |
| CSGP - Costar Group | 1.84% | New | 4,963,185 | $60.41 | $300M | +4,963,185 | +$300M |
| EFX - Equifax | 1.82% | Add +35.6% | 1,617,357 | $182.78 | $296M | +424,654 | +$13M |
| CRM - Salesforce | 1.79% | Add 0.0% | 1,758,938 | $165.04 | $290M | +600 | −$83M |
| V - VISA · CL A | 1.77% | Add +13.2% | 1,462,810 | $196.89 | $288M | +170,957 | +$2M |
| META - Meta Platforms · CL A | 1.77% | Reduce −13.7% | 1,781,040 | $161.25 | $287M | −283,700 | −$172M |
| ADBE - Adobe Systems | 1.60% | Add +0.6% | 710,772 | $366.06 | $260M | +4,400 | −$62M |
| BX - Blackstone | 1.58% | Reduce −3.5% | 2,821,451 | $91.23 | $257M | −102,000 | −$114M |
| AON - AON PLC · CL A | 1.54% | Reduce −8.4% | 928,486 | $269.68 | $250M | −85,500 | −$80M |
| SHW - Sherwin Williams | 1.46% | Reduce −13.3% | 1,062,592 | $223.91 | $238M | −162,500 | −$68M |
| NOW - Servicenow | 1.43% | Reduce −0.4% | 490,150 | $475.52 | $233M | −2,200 | −$41M |
| EXEL - Exelixis | 1.30% | Reduce −3.3% | 10,174,273 | $20.82 | $212M | −345,788 | −$27M |
| NYT - New York Times · CL A | 1.18% | Reduce −6.2% | 6,880,804 | $27.90 | $192M | −457,550 | −$144M |
| BEKE - KE | 1.10% | Add +14.3% | 9,958,500 | $17.95 | $179M | +1,245,000 | +$71M |
| XYZ - Block · CL A | 1.07% | Add +29.3% | 2,839,000 | $61.46 | $174M | +643,000 | −$123M |
| AVTR - Avantor | 1.01% | Add +38.7% | 5,279,464 | $31.10 | $164M | +1,472,352 | +$35M |
| COHR - Coherent | 0.95% | New | 577,982 | $266.22 | $154M | +577,982 | +$154M |
| JAZZ - Jazz Pharmaceuticals | 0.88% | Add +179.7% | 920,100 | $156.01 | $144M | +591,100 | +$92M |
| Lufax · CL A | 0.88% | Add +7.7% | 23,740,399 | $6.00 | $142M | +1,706,000 | +$20M |
| BEAM - Beam Therapeutics | 0.83% | Add +33.8% | 3,472,271 | $38.71 | $134M | +877,884 | −$14M |
| Laboratory Amer | 0.75% | Add +20.6% | 518,714 | $234.36 | $122M | +88,700 | +$8M |
| CVS - Cvs Health | 0.71% | Add +5.1% | 1,246,259 | $92.66 | $115M | +59,976 | −$5M |
| ALNY - Alnylam Pharmaceuticals | 0.71% | Reduce −23.0% | 787,910 | $145.85 | $115M | −235,963 | −$52M |
| SPGI - S&P Global | 0.68% | New | 329,000 | $337.06 | $111M | +329,000 | +$111M |
| UTHR - United Therapeutics | 0.57% | Add +3.4% | 392,696 | $235.64 | $93M | +13,000 | +$24M |
| TSM - Taiwan Semiconductor Mfg | 0.57% | Add +9.5% | 1,126,125 | $81.75 | $92M | +98,000 | −$15M |
| Sarepta Therapeutics | 0.55% | Add +19.5% | 1,185,051 | $74.96 | $89M | +193,076 | +$11M |
| BRKR - Bruker | 0.54% | Add +32.5% | 1,406,800 | $62.76 | $88M | +345,000 | +$20M |
| CYTK - Cytokinetics | 0.54% | Add +19.3% | 2,245,038 | $39.29 | $88M | +362,439 | +$19M |
| ABBV - Abbvie | 0.48% | Reduce −55.8% | 505,515 | $153.16 | $77M | −639,152 | −$108M |
| INSP - Inspire Med Sys | 0.46% | Add +45.7% | 413,000 | $182.67 | $75M | +129,500 | +$3M |
| ENTA - Enanta Pharmaceuticals | 0.45% | Hold | 1,550,000 | $47.27 | $73M | — | — |
| RVMD - Revolution Medicines | 0.39% | Hold | 3,250,000 | $19.49 | $63M | — | — |
| PCG - Pg And E | 0.39% | Hold | 6,305,142 | $9.98 | $63M | — | — |
| Blueprint Medicines | 0.38% | Reduce −10.7% | 1,211,987 | $50.51 | $61M | −145,000 | −$25M |
| BIIB - Biogen | 0.35% | Add +40.8% | 278,499 | $203.94 | $57M | +80,700 | +$15M |
| Catalent | 0.28% | Reduce −41.4% | 419,755 | $107.29 | $45M | −296,800 | −$34M |
| Amyris | 0.24% | Add +25.3% | 21,209,882 | $1.85 | $39M | +4,278,455 | −$35M |
| IOVA - Iovance Biotherapeutics | 0.22% | Reduce −48.6% | 3,176,773 | $11.04 | $35M | −2,998,584 | −$68M |
| Imago Biosciences | 0.20% | Hold | 2,471,313 | $13.39 | $33M | — | — |
| Broadmark Rlty Cap | 0.20% | Hold | 4,850,000 | $6.71 | $33M | — | — |
| Vonage | 0.20% | New | 1,727,000 | $18.84 | $33M | +1,727,000 | +$33M |
| AGIO - Agios Pharmaceuticals | 0.18% | Hold | 1,333,012 | $22.17 | $30M | — | — |
| Marblegate Acquisition · CL A | 0.18% | Hold | 2,970,000 | $9.88 | $29M | — | — |
| PTGX - Protagonist Therapeutics | 0.18% | Add +226.2% | 3,700,608 | $7.91 | $29M | +2,566,151 | +$2M |
| Holding · CL A | 0.17% | Hold | 2,809,000 | $9.74 | $27M | — | — |
| Holding · CL A | 0.17% | Hold | 1,350,500 | $19.97 | $27M | — | — |
| NVAX - Novavax | 0.16% | New | 498,000 | $51.43 | $26M | +498,000 | +$26M |
| Masimo | 0.16% | New | 195,000 | $130.67 | $25M | +195,000 | +$25M |
| Holding · CL A | 0.15% | Hold | 2,500,000 | $9.75 | $24M | — | — |
| Metals Acquisition · CL A | 0.15% | Hold | 2,489,700 | $9.79 | $24M | — | — |
| Berenson Acquisition I · CL A | 0.15% | Hold | 2,475,000 | $9.76 | $24M | — | — |
| Cara Therapeutics | 0.14% | Hold | 2,500,000 | $9.13 | $23M | — | — |
| Atento S A | 0.14% | Hold | 2,230,357 | $9.99 | $22M | — | — |
| Radius Health | 0.13% | Hold | 2,107,400 | $10.37 | $22M | — | — |
| Revolution Healthcar Aq · CLASS A | 0.12% | Hold | 2,000,000 | $9.76 | $20M | — | — |
| Swiftmerge Acquisition · CLASS A | 0.12% | Hold | 1,980,000 | $9.82 | $19M | — | — |
| Generation Bio | 0.12% | Reduce −17.2% | 2,897,300 | $6.56 | $19M | −602,700 | −$7M |
| Holding · CLASS A | 0.11% | Hold | 1,900,000 | $9.72 | $18M | — | — |
| Sanderson Farms | 0.11% | New | 80,000 | $215.52 | $17M | +80,000 | +$17M |
| Holding · CLASS A | 0.11% | Hold | 1,732,500 | $9.89 | $17M | — | — |
| Fortress Value Acquisi · CL A | 0.11% | Hold | 1,750,000 | $9.77 | $17M | — | — |
| Sdcl Edge Acquisition · CL A | 0.10% | Hold | 1,732,500 | $9.75 | $17M | — | — |
| Vector Acquisition Ii · CL A | 0.10% | Hold | 1,700,000 | $9.80 | $17M | — | — |
| Shelter Acquisition I · CLASS A | 0.10% | Hold | 1,650,000 | $9.83 | $16M | — | — |
| Big Sky Growth Partners · CLASS A | 0.09% | Hold | 1,550,000 | $9.74 | $15M | — | — |
| KKR - Kkr Acquisition I · CLASS A | 0.09% | Hold | 1,500,000 | $9.79 | $15M | — | — |
| Holding · CL A | 0.09% | Hold | 1,500,000 | $9.75 | $15M | — | — |
| Savara | 0.09% | Add +12.6% | 9,577,273 | $1.52 | $15M | +1,071,870 | +$3M |
| Ares Acquisition · CL A | 0.09% | Hold | 1,425,000 | $9.83 | $14M | — | — |
| Healthcare Tr Amer · CL A | 0.09% | New | 500,000 | $27.91 | $14M | +500,000 | +$14M |
| Humanco Acquisition · CL A | 0.09% | Hold | 1,407,749 | $9.85 | $14M | — | — |
| Disruptive Acquisition · CLASS A | 0.08% | Hold | 1,400,000 | $9.78 | $14M | — | — |
| Holding · CLASS A | 0.08% | Hold | 1,360,040 | $9.76 | $13M | — | — |
| Karuna Therapeutics | 0.08% | Reduce −71.4% | 100,000 | $126.51 | $13M | −250,000 | −$32M |
| Forest Road Acquisition Cor · CL A | 0.08% | Hold | 1,250,000 | $9.80 | $12M | — | — |
| CRBU - Caribou Biosciences | 0.07% | Reduce −17.1% | 2,203,895 | $5.43 | $12M | −453,157 | −$12M |
| GPOR - Gulfport Energy | 0.07% | Reduce −51.8% | 150,326 | $79.51 | $12M | −161,519 | −$16M |
| Holding · CL A | 0.07% | Hold | 1,208,326 | $9.81 | $12M | — | — |
| Tcv Acquisition · CL A | 0.07% | Hold | 1,211,459 | $9.75 | $12M | — | — |
| Agile Growth · CLASS A | 0.07% | Hold | 1,200,000 | $9.82 | $12M | — | — |
| Nightdragon Acquisition · CLASS A | 0.07% | Hold | 1,200,000 | $9.74 | $12M | — | — |
| Ventyx Biosciences | 0.07% | Reduce −16.5% | 930,648 | $12.23 | $11M | −183,632 | −$4M |
| Gores Vii · CL A | 0.07% | Hold | 1,150,162 | $9.78 | $11M | — | — |
| Tiga Acquisition · CL A | 0.07% | Hold | 1,080,000 | $10.27 | $11M | — | — |
| Holding · CL A | 0.07% | Hold | 1,120,102 | $9.81 | $11M | — | — |
| Tpg Pace Beneficial Ii | 0.07% | Hold | 1,116,833 | $9.73 | $11M | — | — |
| Concord Acquisition · CL A | 0.06% | Hold | 1,005,100 | $9.96 | $10M | — | — |
| Holding · CLASS A | 0.06% | Hold | 985,300 | $9.95 | $10M | — | — |
| Holding · CLASS A | 0.06% | Hold | 1,000,000 | $9.80 | $10M | — | — |
| Churchill Capital Vii · CL A | 0.06% | Hold | 1,000,000 | $9.77 | $10M | — | — |
| Forum Merger Iv · CLASS A | 0.06% | Hold | 1,000,000 | $9.77 | $10M | — | — |
| Churchill Capital Vi · CL A | 0.06% | Add +27.5% | 997,767 | $9.79 | $10M | +215,000 | +$2M |
| Screaming Eagle Acquisitn · CLASS A | 0.06% | Hold | 1,000,000 | $9.59 | $10M | — | — |
| NUVB - Nuvation Bio · CL A | 0.06% | Hold | 2,900,000 | $3.24 | $9M | — | — |
| COGT - Cogent Biosciences | 0.06% | Add +17.6% | 1,000,000 | $9.02 | $9M | +150,000 | +$3M |
| Holding · CL A | 0.06% | Hold | 900,000 | $10.00 | $9M | — | — |
| Interprivate Ii Acquisition · CL A | 0.05% | Hold | 882,647 | $9.79 | $9M | — | — |
| Rxr Acquisition · CLASS A | 0.05% | Hold | 854,961 | $9.79 | $8M | — | — |
| Holding · CLASS A | 0.05% | Hold | 843,046 | $9.79 | $8M | — | — |
| Holding | 0.05% | Hold | 848,184 | $9.70 | $8M | — | — |
| NTRA - Natera | 0.05% | Reduce −79.1% | 230,552 | $35.44 | $8M | −870,700 | −$37M |
| Holding · CLASS A | 0.05% | Hold | 835,638 | $9.74 | $8M | — | — |
| Holding · CL A | 0.05% | Hold | 800,000 | $9.83 | $8M | — | — |
| Arya Sciences Acqu Iv · CL A | 0.05% | Hold | 800,000 | $9.82 | $8M | — | — |
| Landcadia Iv · CLASS A | 0.05% | Hold | 802,028 | $9.79 | $8M | — | — |
| Levere · CLASS A | 0.05% | Hold | 800,000 | $9.78 | $8M | — | — |
| Holding · CL A | 0.05% | Hold | 775,200 | $9.89 | $8M | — | — |
| Holding · CLASS A | 0.05% | Hold | 750,000 | $9.96 | $7M | — | — |
| Holding · CL A | 0.05% | Hold | 750,000 | $9.83 | $7M | — | — |
| Social Leverage Acquisn · CL A | 0.05% | Hold | 750,000 | $9.83 | $7M | — | — |
| Pathfinder Acquisition · CL A | 0.05% | Hold | 750,000 | $9.82 | $7M | — | — |
| Research Alliance Ii · CL A | 0.05% | Hold | 750,000 | $9.80 | $7M | — | — |
| Holding · CL A | 0.05% | Hold | 750,000 | $9.80 | $7M | — | — |
| Panacea Acquisition Ii · CL A | 0.05% | Hold | 750,000 | $9.77 | $7M | — | — |
| Holding · CLASS A | 0.04% | Hold | 745,000 | $9.72 | $7M | — | — |
| Holding · CL A | 0.04% | Hold | 700,000 | $9.78 | $7M | — | — |
| Khosla Ventures Acquisition · CL A | 0.04% | Hold | 700,000 | $9.75 | $7M | — | — |
| Gores Viii · CL A | 0.04% | Hold | 692,810 | $9.85 | $7M | — | — |
| Corsair Partnering · CL A | 0.04% | Hold | 700,000 | $9.68 | $7M | — | — |
| Rocket Internet Grwt Oprt · CL A | 0.04% | Hold | 647,945 | $9.78 | $6M | — | — |
| Rcf Acquisition · CL A | 0.04% | Hold | 600,000 | $9.96 | $6M | — | — |
| Finserv Acquisition Ii · CL A | 0.04% | Hold | 600,000 | $9.80 | $6M | — | — |
| Holding · CLASS A | 0.04% | Hold | 600,000 | $9.80 | $6M | — | — |
| Cdk Global | 0.04% | Reduce −71.2% | 106,514 | $54.77 | $6M | −263,486 | −$12M |
| Ready Capital | 0.03% | Reduce −11.7% | 472,537 | $11.92 | $6M | −62,363 | −$2M |
| SLAM · CL A | 0.03% | Hold | 570,396 | $9.81 | $6M | — | — |
| Blue Whale Acquisition · CLASS A | 0.03% | Hold | 575,000 | $9.67 | $6M | — | — |
| G Squared Ascend I · CL A | 0.03% | Hold | 500,000 | $9.81 | $5M | — | — |
| Tio Tech A · CLASS A | 0.03% | Hold | 502,001 | $9.77 | $5M | — | — |
| Ftac Hera Acquisition · CLASS A | 0.03% | Hold | 500,000 | $9.80 | $5M | — | — |
| Holding · CL A | 0.03% | Hold | 500,000 | $9.79 | $5M | — | — |
| Gores Ix · CLASS A | 0.03% | Hold | 500,000 | $9.62 | $5M | — | — |
| Holding · CL A | 0.03% | Hold | 484,709 | $9.77 | $5M | — | — |
| Holding · CLASS A | 0.03% | Hold | 452,519 | $9.79 | $4M | — | — |
| Scion Tech Growth Ii · CL A | 0.03% | Hold | 450,000 | $9.80 | $4M | — | — |
| Ldh Growth I · CLASS A | 0.03% | Hold | 436,702 | $9.77 | $4M | — | — |
| QTRX - Quanterix | 0.03% | Reduce −52.3% | 260,000 | $16.19 | $4M | −285,000 | −$12M |
| Svf Investment · CL A | 0.03% | Hold | 425,000 | $9.86 | $4M | — | — |
| Vpc Impact Acquisition · CLASS A | 0.03% | Hold | 425,000 | $9.80 | $4M | — | — |
| ALVO - Alvotech | 0.03% | New | 500,000 | $8.21 | $4M | +500,000 | +$4M |
| Lamf Global Ventures I · CLASS A | 0.02% | Hold | 400,000 | $9.96 | $4M | — | — |
| Holding · CL A | 0.02% | Hold | 400,000 | $9.80 | $4M | — | — |
| Holding · CLASS A | 0.02% | Hold | 400,000 | $9.77 | $4M | — | — |
| Cartica Acquisition · CLASS A | 0.02% | Hold | 350,000 | $10.02 | $4M | — | — |
| Holding · CLASS A | 0.02% | Hold | 350,000 | $9.98 | $3M | — | — |
| Uta Acquisition · CLASS A | 0.02% | Reduce −1.7% | 344,100 | $9.92 | $3M | −5,900 | −$36K |
| Sound Point Acquisition · CLASS A | 0.02% | New | 300,000 | $10.06 | $3M | +300,000 | +$3M |
| Holding · CL A | 0.02% | Hold | 304,698 | $9.77 | $3M | — | — |
| Holding · CLASS A | 0.02% | Hold | 300,000 | $9.92 | $3M | — | — |
| Lazard Growth Acquisition · CL A | 0.02% | Hold | 300,000 | $9.78 | $3M | — | — |
| RCEL - Avita Medical | 0.02% | Reduce −27.5% | 580,000 | $4.75 | $3M | −220,000 | −$4M |
| Holding | 0.02% | Hold | 810,500 | $3.09 | $3M | — | — |
| Broadscale Acquisition · CL A | 0.02% | Hold | 250,000 | $9.82 | $2M | — | — |
| Hudson Executive Inves Iii · CL A | 0.02% | Hold | 250,000 | $9.80 | $2M | — | — |
| Live Oak Mobility Acquisi · CL A | 0.02% | Hold | 250,000 | $9.80 | $2M | — | — |
| Clever Leaves | 0.01% | Add +1.3% | 2,466,892 | $0.9757 | $2M | +30,461 | −$4M |
| Theseus Pharmaceuticals | 0.01% | Reduce −21.8% | 409,717 | $5.53 | $2M | −114,262 | −$4M |
| Liberty Media Acquisition | 0.01% | Add +81.6% | 210,000 | $9.84 | $2M | +94,342 | +$920K |
| Arctos Northstar Acquis · CL A | 0.01% | Hold | 200,000 | $9.82 | $2M | — | — |
| Better Therapeutics | 0.01% | Reduce −12.8% | 1,000,000 | $1.56 | $2M | −147,400 | −$712K |
| Priveterra Acquisition · CL A | 0.01% | Hold | 150,000 | $9.80 | $1M | — | — |
| TNGX - Tango Therapeutics | 0.01% | Hold | 300,000 | $4.53 | $1M | — | — |
| Ikena Oncology | 0.01% | Reduce −63.4% | 290,000 | $4.43 | $1M | −502,077 | −$4M |
| The Music Acquisition · CLASS A | 0.01% | Hold | 125,000 | $9.80 | $1M | — | — |
| Lianbio | 0.01% | New | 500,000 | $2.16 | $1M | +500,000 | +$1M |
| Crypto 1 Acquisition · CLASS A | 0.01% | Hold | 100,000 | $9.91 | $991K | — | — |
| NTRS - Northern Trust · CL A | 0.01% | Hold | 100,000 | $9.80 | $980K | — | — |
| NTRS - Northern Trust · CL A | 0.01% | Hold | 100,000 | $9.80 | $980K | — | — |
| OKLO - Altc Acquisition · CL A | 0.01% | Hold | 98,300 | $9.65 | $949K | — | — |
| Avrobio | 0.00% | Hold | 740,000 | $0.9203 | $681K | — | — |
| Summit Midstream Partners | 0.00% | Hold | 43,055 | $12.73 | $548K | — | — |
| Ion Acquisition 3 · CL A | 0.00% | Hold | 56,151 | $9.74 | $547K | — | — |
| ANNX - Annexon | 0.00% | Reduce −49.2% | 130,000 | $3.77 | $490K | −125,705 | −$208K |
| Holding | 0.00% | Hold | 85,838 | $3.41 | $293K | — | — |
Showing top 50 of 190 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2022 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| RTX - Raytheon Technologies | 1.78% | Exit | 0 | $99.07 | $335M | −3,385,484 | −$335M |
| AVGO - Broadcom | 1.37% | Exit | 0 | $629.68 | $257M | −408,850 | −$257M |
| Zendesk | 0.40% | Exit | 0 | $120.29 | $76M | −630,000 | −$76M |
| Exact Sciences | 0.30% | Exit | 0 | $69.92 | $56M | −802,898 | −$56M |
| DIDIY - Didi Global | 0.22% | Exit | 0 | $2.50 | $42M | −16,868,328 | −$42M |
| RGEN - Repligen | 0.22% | Exit | 0 | $188.09 | $42M | −222,979 | −$42M |
| Mantech International · CL A | 0.17% | Exit | 0 | $86.19 | $32M | −375,000 | −$32M |
| VEON - Veoneer | 0.08% | Exit | 0 | $36.95 | $16M | −427,500 | −$16M |
| PACB — | 0.08% | Exit | 0 | $9.10 | $15M | −1,631,800 | −$15M |
| Cascade Acquisition · CL A | 0.05% | Exit | 0 | $10.08 | $10M | −990,000 | −$10M |
| Holding · CL A | 0.05% | Exit | 0 | $9.86 | $10M | −1,000,000 | −$10M |
| Peoples United Financial | 0.05% | Exit | 0 | $19.99 | $10M | −485,000 | −$10M |
| Zealand Pharma A/S | 0.04% | Exit | 0 | $15.59 | $8M | −496,890 | −$8M |
| ARWR - Arrowhead Pharmaceuticals | 0.03% | Exit | 0 | $45.99 | $7M | −142,700 | −$7M |
| Holding | 0.03% | Exit | 0 | $34.64 | $6M | −169,458 | −$6M |
| Point Biopharma Global | 0.03% | Exit | 0 | $7.97 | $5M | −626,322 | −$5M |
| Fibrogen | 0.02% | Exit | 0 | $12.02 | $4M | −364,764 | −$4M |
| Sound Point Acquisition | 0.02% | Exit | 0 | $10.06 | $3M | −300,000 | −$3M |
| Ferro | 0.01% | Exit | 0 | $21.74 | $2M | −114,963 | −$2M |
| FATE - Fate Therapeutics | 0.01% | Exit | 0 | $38.78 | $1M | −31,900 | −$1M |
| Holding | 0.01% | Exit | 0 | $10.07 | $1M | −100,000 | −$1M |
| VCYT - Veracyte | — | Exit | 0 | $27.57 | $896K | −32,500 | −$896K |
| CMPX - Compass Therapeutics | — | Exit | 0 | $1.37 | $798K | −582,750 | −$798K |
| Dariohealth | — | Exit | 0 | $5.84 | $777K | −133,083 | −$777K |
| Holding | — | Exit | 0 | $1.15 | $150K | −130,000 | −$150K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2